RLJ (53) ARR (63) SMA (53) FRMI (34) ⌘ Pro Terminal →

Diversified Healthcare Trust of (DHC) — RQD Stock Rating Cockpit

$7.97 +2.18% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $7.99

Diversified Healthcare Trust of (DHC) carries a Roarable Rating of D- (Sell) with 36/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (36/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $1.93B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $7.99 (+0.20%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 3/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (36/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.3% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-9.9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for DHC)Realized 20D OHLCV Swing Band: ±6.6%

Deterministic 5-Pillar Attribution (36/100 Composite)

🔍 WHY DHC SCORES 36/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+13/20 pts (36% of score)

20D Institutional Volume Accumulation (±6.6% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+10/20 pts (28% of score)

FRED Regime × Technicals: 71% of 52W Range • RSI-14 at 50.5 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$7.50+1.2% Next Q

Q2 (-2Q)

Grade E$7.59+3.6% Next Q

Q3 (-1Q)

Grade E$7.86+1.4% Next Q

Current

Grade D-$7.97-8.3% Hist 90D α

Trajectory: E (28) → D- (36)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a DHC Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While DHC currently carries a cautious 36/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Financials with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($7.77) and Max Pain ($8.37) forces dealer call-delta covering toward $10.14.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $DHC• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “DHC Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 36%NO 64%Trade / Inspect Odds →

RSI-14 MOMENTUMNEUTRAL RANGE

50.530 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.80>3.0 Fortress Safe

PIOTROSKI F-SCOREWEAK QUALITY (1–4)

2 / 99-Pt Accounting

52-WEEK LASER RANGE71% OF RANGE

L: $4$7.97H: $10

1. Money & Cash Health● WEAK

Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: ERQD 2 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: D-RQD 16 / 40

3. Hidden Risks & Market Weather● WARNING

SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: DRQD 18 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bearish Warning on DHC

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BEARISH (15)

-17.2% ROIC with 42.0% gross margin and -1.02% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BEARISH (40)

Altman-Z 4.20 and Piotroski 2/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BEARISH (43)

16/40 institutional & smart-money positioning score with 10/20 macro alignment.

Bull Case: Why Buyers Like DHC

✓Established market leader in Financials with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Company executives have done more routine share selling than personal cash buying lately.
!Sensitive to high interest rates and tighter Federal Reserve market liquidity.
!Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring DHC)

✓Walkthrough of DHC's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

DHC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +5.70%📐 HORIZONTAL RANGE

2026-10-30O $8.00H $8.02L $7.68C $7.97VOL 1.65M

RES: $10.54SUP: $6.99SMA50: $7.77SMA200: $7.77

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

DHC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 DHC Butterfly Map → + Track DHC →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +2.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on DHC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for DHC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for DHC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (DHC)

Financials Rank #1020 of 1096 ⚔️ RLJ vs DHC Full Matrix →

1. Head-to-Head Financials Peer Comparison (DHC vs. RLJ, ARR, SMA, FRMI)

Industry: Real Estate Investment Trusts (172 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, Diversified Healthcare Trust of (DHC) ranks #1020 by composite RQD confidence (36/100, grade D-) and #431 by equity capitalization ($1.93B). Within this direct 5-issuer industry benchmark cohort, ARR leads on earnings valuation at 5.9x trailing P/E, while ARR leads on capital efficiency and profitability with 14.3% ROIC and — gross margin. ARR currently holds the highest overall quantitative score in the immediate peer group at 63/100 (C) compared with DHC at 36/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
DHC ACTIVE Diversified Healthcare Trust of	D-	36/100	—	—	-17.2%	+2.18%	$1.93B	Benchmark Subject
RLJ RLJ Lodging Trust of $0.01 par value	D+	53/100	67.9x	—	1.3%	+1.68%	$1.94B	/rlj-vs-dhc →
ARR ARMOUR Residential REIT Inc.	C	63/100	5.9x	—	14.3%	+0.95%	$1.90B	/arr-vs-dhc →
SMA SmartStop Self Storage REIT Inc.	D+	53/100	—	—	4.1%	+1.53%	$1.98B	/sma-vs-dhc →
FRMI Fermi Inc.	E	34/100	—	—	-20.4%	-5.30%	$1.83B	/frmi-vs-dhc →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001075415

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Diversified Healthcare Trust of (DHC) reported GAAP revenue of $1.54B (+2.8% vs. FY2024 revenue of $1.50B , and +9.0% cumulative change since FY2023) , GAAP net income of -$285.9M, operating cash flow of -$19.6M, and free cash flow of -$19.6M (-117.5% YoY). On the balance sheet, DHC closed FY2025 with $4.36B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.54B	-$285.9M	-$19.6M	-$19.6M	$4.36B	—
FY2024 (FY)	2024-12-31	$1.50B	-$370.3M	$112.2M	$112.2M	$5.14B	—
FY2023 (FY)	2023-12-31	$1.41B	-$293.6M	$10.5M	$10.5M	—	—

3. DHC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is DHC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Diversified Healthcare Trust of (NASDAQ: DHC) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 36/100 at a spot price of $7.97 (+2.18% 1D, market cap $1.93B). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 3/20. Across 1096 tracked Financials issuers, DHC ranks #1020 in composite RQD confidence.

How does DHC compare to RLJ and ARR in the Financials sector?

Within the Financials sector (Real Estate Investment Trusts), DHC carries a Roarable D- (36/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -17.2%. By comparison, RLJ (RLJ Lodging Trust of $0.01 par value) holds a D+ grade (53/100 RQD, P/E 67.9x, ROIC 1.3%, cap $1.94B) and ARR (ARMOUR Residential REIT Inc.) posts a C grade (63/100 RQD, P/E 5.9x, ROIC 14.3%, cap $1.90B). Among the 5-stock peer group, ARR leads on earnings multiple (5.9x) while ARR leads on capital efficiency (14.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for DHC?

Per DHC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001075415), Diversified Healthcare Trust of generated $1.54B in revenue (+2.8% YoY), -$285.9M in net income, and -$19.6M in free cash flow against $4.36B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is DHC trading relative to its 50-day, 200-day, and 52-week technical levels?

DHC last traded at $7.97 (+2.18% on volume of 1,630,163 shares), positioning the stock +2.57% above its 50-day simple moving average ($7.77) and +2.57% above its 200-day simple moving average ($7.77). Across its 52-week range of $3.92 to $9.66, DHC sits at the 70.6% percentile with a 14-day RSI of 50.5 (NEUTRAL RANGE) and an implied next-earnings move of ±6.6% ($7.44 to $8.50).

DHC Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell DHC stock right now?

Diversified Healthcare Trust of (DHC) currently earns a Roarable Rating of D- (Sell — SELL) with 36/100 RQD Confidence. Stretched risk/reward at current multiples (-17% return on capital) under elevated 10-year interest-rate pressure.

What is DHC's 12-month price target and RQD AI Jury consensus?

DHC's 12-month base price target is $7.18 (range $5.6 to $10.14), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: DHC RQD Cockpit DHC 12M Forecast DHC Earnings & Move DHC Dividends & DRIP DHC Insiders & 13F DHC Whale Options DHC Profit Sankey DHC News & Why